Telmisartan Attenuates Diabetic Nephropathy by Suppressing Oxidative Stress in db/db Mice

A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy

(2011) Yashpal S. Kanwar et al.   Annual Review of Pathology-Mechanisms of Disease

Oxidative Stress and Diabetic Kidney Disease

(2011) Robert C. Stanton   Current Diabetes Reports

Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes

(2011) R. Kodera et al.   DIABETOLOGIA

Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1–7)masreceptor expression associated with its PPAR-γ agonist action

(2011) Arun Prasath Lakshmanan et al.   FREE RADICAL RESEARCH

The contribution of hypertension to diabetic nephropathy and retinopathy: the role of inflammation and oxidative stress

(2011) José Butori Lopes de Faria et al.   HYPERTENSION RESEARCH

The Effect of Obesity on Chronic Kidney Disease

(2011) Joel D. Kopple et al.   JOURNAL OF RENAL NUTRITION

Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic Nephropathy

(2011) M. Lin et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production

(2011) J. Toyonaga et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Toward a More Complete (and Less Controversial) Understanding of Energy Expenditure and Its Role in Obesity Pathogenesis

(2010) K. J. Kaiyala et al.   DIABETES

The therapeutics of lifestyle management on obesity

(2010) P. A. Dyson   DIABETES OBESITY & METABOLISM

Reactive Oxygen Species Promote Caspase-12 Expression and Tubular Apoptosis in Diabetic Nephropathy

(2010) M. L. Brezniceanu et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Oxidative stress in early diabetic nephropathy: fueling the fire

(2010) Dhruv K. Singh et al.   Nature Reviews Endocrinology

The RAAS in the pathogenesis and treatment of diabetic nephropathy

(2010) Piero Ruggenenti et al.   Nature Reviews Nephrology

Nephroprotective Effect of Telmisartan in Rats with Ischemia/Reperfusion Renal Injury

(2010) Amr A. Fouad et al.   PHARMACOLOGY

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes

(2009) Y. F. Dong et al.   DIABETOLOGIA

Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue

(2009) Hiroshi Kudo et al.   LIVER INTERNATIONAL

Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity

(2009) Mohamed A. Ibrahim et al.   PHARMACOLOGICAL RESEARCH

Rap1b GTPase Ameliorates Glucose-Induced Mitochondrial Dysfunction

(2008) L. Sun et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy

(2008) George Bakris et al.   KIDNEY INTERNATIONAL